Nutrition Support in Bone Marrow Transplant Recipients

Nutrition in Clinical Practice

Volumn 8, Issue 1, 1993, Pages 19-27

  Herrmann, Virginia M ^a   Petruska, Paul J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; ENTERIC FEEDING; HUMAN; METHODOLOGY; NUTRITION; NUTRITIONAL DISORDER; REVIEW; TOTAL PARENTERAL NUTRITION;

BONE MARROW TRANSPLANTATION; ENTERAL NUTRITION; HUMAN; NUTRITION ASSESSMENT; NUTRITION DISORDERS; PARENTERAL NUTRITION, TOTAL;

EID: 0027546888     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/011542659300800119     Document Type: Article

References (105)

1. Storb R. Critical issues in bone marrow transplantation. Transplant Proc 1987; 19: 2774-81.
2. Blume K.G., Petz L.D., eds. Clinical bone marrow transplantation. New York: Churchill Livingstone, 1983.
3. Gale R.P., Armitage J.O., Dickie K.A. Autotransplants: now and in the future. Bone Marrow Transplant 1991; 7: 153-7.
4. Thomas E.D. Current status of bone marrow transplantation. Transplant Proc 1985; 17: 428-43.
5. Brockstein J.A. Critical care issues in bone marrow transplantation. Crit Care Clin 1988; 4: 147-66.
6. Champlin R.E., Gale R.P. The early complications of bone marrow transplantation. Semin Hematol 1984; 21: 101-8.
7. Tutschka P.J. Complications of bone marrow transplantation. Am J Med Sci 1987; 294: 86-90.
8. Santos G.W., Kaizer H. Bone marrow transplantation in acute leukemia. Semin Hematol 1982; 19: 227-37.
9. Friedrich T., Piischel W., Helbig W., Lethal complications in 30 patients after allogeneic BMT (BMT) and autografted (ABMT) patients (1980-1986) examined by autopsy. Folia Haematol (Leipz) 1989;116: 585-9.
10. Krowka M.J., Rosenow E.C. III, Hoagland H.C. Pulmonary complications of bone marrow transplantation. Chest 1985; 87: 237-46.
11. Afessa B., Tefferi A., Hoagland H.C., Outcome of recipients of bone marrow transplants who require intensive care unit support. Mayo Clin Proc 1992; 67: 117-22.
12. Dieg H.J., Storb R. Graft versus host disease: patho-physiological and clinical aspects. Annu Rev Med 1984; 35: 11-24.
13. Brass D.S., Tutschka P.J., Farmer E.R., Predictive factors for acute graft versus host disease in patients transplanted with HLA identical bone marrow. Blood 1984; 63: 1265-70.
14. Aker S.N. Oral feedings in the cancer patients. Cancer 1979; 43(suppl):2: 103-7.
15. Wolford J.L., McDonald G.B. A problem-oriented approach to intestinal and liver disease after marrow transplantation. J Clin Gastroenterol 1988; 10: 419-33.
16. Keenan A.M.M. Nutritional support of the bone marrow transplant patient. Nurs Clin North Am 1989; 24: 383-93.
17. Liddell S., Applebaum J.R., Buckner C.D., High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. J Clin Oncol 1988; 6: 576-82.
18. McDonald G.B., Sharma P., Hackman R.C., Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology 1985; 88: 1111-7.
19. Schubert M.M., Sullivan K.M., Truelove E.L. Head and neck complications of bone marrow transplantation. In: Peterson E.D., Sonis S.B., Elias E.G., eds. Head and neck management of the cancer patient. Boston: Martenus Nijhoff, 1986: 401-27.
20. Boock C.A., Reddick J.E. Taste alterations in bone marrow transplant patients. J Am Diet Assoc 1991; 91: 1121-2.
21. Barole K., Aker S.N., Martensen C.S. Primary taste threshold in children with leukemia undergoing marrow transplantation. JPEN 1982; 6: 287-90.
22. Gauvreau-Gern J.M., Cheney C.L., Aker S.N., Food intake patterns and food service requirements on a marrow transplant unit. J Am Diet Assoc 1989; 89: 367-72.
23. Lenssen P., Sherry M.E., Cheney C.L., Prevalence ofnutritionrelated problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc 1990; 90: 835-42.
24. Nunnally C. Taste alterations. In: Yasko J.M., ed. Guidelines for cancer care, symptom management. Reston, VA: Reston Publishing Company, 1983: 224-9.
25. Hansen B.W., De Somery D.H., Hagedorn L.W. Effects of enteral and parenteral nutrition on appetite in monkeys. JPEN 1977; 1: 83-88.
26. McDonald G.B., Sale G.E. The human gastrointestinal tract after allogeneic marrow transplantation. In: Sale G.E., Shulman H.M., eds. The pathology of bone marrow transplantation. New York: Masson, 1984: 77-103.
27. Epstein R.J., McDonald G.B., Sale G.E., The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology 1980; 78: 764-71.
28. Sale G.E., Shulman H.M., McDonald G.B., Gastrointestinal graft versus host disease in man: a clinicopathologic study of the rectal biopsy. Am J Surg Pathol 1979; 3: 291-9.
29. Weisdorf S.A., Salati L.M., Longsdorf J.A., Graft versus host disease of the intestine: a protein losing enteropathy characterized by fecal alpha-1-antitrypsin. Gastroenterology 1983; 85: 1076-81.
30. McDonald G.B., Shulman H.M., Sullivan K.M., Intestinal and hepatic complications of human bone marrow transplantation. Gastroenterology 1986; 90: 460-77.
31. Fegan C., Poynton C.H., Whittaker J.A. The gut mucosal barrier in bone marrow transplantation. Bone Marrow Transplant 1990; 5: 373-7.
32. Spencer G.D., Shulman H.M., Myerson D., Diffuse intestinal ulceration after marrow transplantation. A clinical-pathological study of 13 patients. Hum Pathol 1986; 17: 621-33.
33. Beschorner W.E., Yardley J.H., Tutschka P., Deficiency of intestinal immunity with graft versus host disease in humans. J Infect Dis 1981; 144: 38-46.
34. Parelli G., Iaffaioli R.V., Capuano G., Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy. Cancer Treat Rep 1982; 66: 1435-6.
35. Guiot H.F.L., Biemond J., Klasen E., Protein loss during acute graft versus host disease: diagnostic and clinical significance. Eur J Haematol 1987; 38: 187-96.
36. Champlin R., Gale R.P. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. Semin Hematol 1987; 24: 55-67.
37. McDonald G.B., Shulman H.M., Wolford J.L., Liver disease after human marrow transplantation. Semin Liver Dis 1987; 7: 210-19.
38. McDonald G.B., Sharma P., Matthews D.E., Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116-22.
39. Jone R.J., Lee KSK, Beschorner W.E., Veno-occlusive disease following marrow transplantation. Transplantation 1987; 44: 778-83.
40. McDonald G.B., Sharma P., Matthews D.E., The clinical course of 53 patients with veno-occlusive disease of the liver after marrow transplantation. Transplantation 1985; 36: 603-8.
41. Moore F.D., Olesen K.H., McMurrey H.V., Body composition in health and disease. Philadelphia: W.B. Saunders, 1963.
42. Szeluga O.J., Stuart R.K., Utermohlen V., Nutritional assessment by isotope dilution analysis of body composition. Am J Clin Nutr 1984; 40: 847-54.
43. Cheney C.L., Abson K.G., Aker S.N., Body composition changes in marrow transplant recipients receiving total parenteral nutrition. Cancer 1987; 59: 1515-9.
44. Cheney C.L., Lenssen P., Aker S.N., Sex differences in nitrogen balance following marrow grafting for leukemia. J Am Coll Nutr 1987; 6: 223-30.
45. Keller U., Kraenzlin M.E., Gratwohl A., Protein metabolism assessed by 1-13C leucine infusions in patients undergoing bone marrow transplantation. JPEN 1990; 14: 480-4.
46. Herrmann V.M., Sarnick M.B., Moore F.D., Effect of cytotoxic agents on protein kinetics in patients with metastatic cancer. Surgery 1981; 90: 1-387.
47. Desai T.K., Maliakkal J., Kinzie J.L., Taurine deficiency after intensive chemotherapy and/or radiation. Am J Clin Nutr 1992; 55: 708-11.
48. Abe M., Takahashi M., Takeuchi K., Studies on the significance of taurine in radiation injury. Radiat Res 1968; 33: 563-73.
49. Kaduk B., Husslein E.M., Seigrick A. Morphology of the chronic toxicity of busulfan or the islets of Langerhans in the rat. Hepatogastroenterology 1987; 34: 108-12.
50. Harris K.P.G., Russell G.I., Parvin S.D., Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant patients. Br Med J 1986; 292-6.
51. Ost L., Tyden G., Fehrman I. Impaired glucose tolerance in cyclosporine-prednisone treated renal graft recipients. Transplantation 1988; 46: 370-2.
52. Smedmyr B., Wibbell L., Simonsson B., Impaired glucose tolerance after autologous bone marrow transplantation. Bone Marrow Transplant 1990; 6: 89-92.
53. Schouten H.C., Maragos D., Vose J., Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation. Bone Marrow Transplant 1990; 6: 333-5.
54. Storb R., Deeg H.J., Fisher L., Cyclosporine versus methotrexate for graft versus host disease prevention in patients given marrow grafts for leukemia. Long-term follow-up of three controlled trials. Blood 1988; 71: 293-8.
55. Ringden O., Backman L., Lonngvist B., A randomized trial comparing use of cyclosporine and methotrexate for graft versus host prophylaxis in bone marrow transplantation recipients with hematological malignancies. Bone Marrow Transplant 1986; 1: 41-51.
56. Raine A.E.G., Carter R., Mann J.I., Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression. Transplant Proc 1987; 19: 1820-1.
57. Nemunaitis J., Deeg H.J., Yel G.C. High cyclosporine concentrations after bone marrow transplantation associated with hypertriglyc-eridemia. Lancet 1986; 2: 744-5.
58. Carreras E., Villamor J.C., Reverter J., Hypertriglycoidemia in bone marrow transplant recipients: another side effect of cyclosporin A. Bone Marrow Transplant 1989; 4: 385-8.
59. Carlin A., Walker W.A. Rapid development of vitamin K deficiency in an adolescent boy receiving total parenteral nutrition following bone marrow transplantation. Nutr Rev 1991; 49: 179-83.
60. Conly J., Suttie J., Reid E., Dietary deficiency of phylloquinone and reduced serum concentrations in febrile neutropenic cancer patients. Am J Clin Nutr 1989; 50: 109-13.
61. Milligan D.W., Quick A., Barnard D.L. Vitamin B12 absorption after allogeneic bone marrow transplantation. J Clin Pathol 1987;40: 1472-4.
62. Rovelli A., Bonomi M., Murano A., Severe lactic acidosis due to thiamine deficiency after bone marrow transplantation in a child with acute monocytic leukemia. Haematologica 1990; 75: 579-89.
63. Clemens M.R., Ladner C., Schmidt H., Decreased essential antioxidants and increased lipid hydroperoxidases following high-dose radiochemotherapy. Free Rad Res Comms 1989; 7: 227-32.
64. Clemens M.R., Ladner C., Ehninger G., Plasma vitamin E and ß-carotene concentrations during radiochemotherapy preceding bone marrow transplantation. Am J Clin Nutr 1990; 51: 216-9.
65. Burton G.W., Joyce A., Ingold K. First proof that vitamin E is a major lipid-soluble, chain-breaking antioxidant in human blood plasma. Lancet 1982; 2: 327.
66. Burton G.W., Ingold K. Beta-carotene: an unusual type of antioxidant. Science 1984; 224: 569-73.
67. June C.H., Thompson C.B., Kennedy M.S., Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 1985; 39: 620.
68. June C.H., Thompson C.B., Kennedy M.S., Correlation of hypomagnesemia with the onset of cyclosporine associated hypertension in marrow transplant patients. Transplantation 1986; 41: 47-51.
69. Beguin Y., Brasseur F., Weber G., Observations of serum trace elements in chronic lymphocytic leukemia. Cancer 1987; 60: 1842-6.
70. Beguin Y., Weber G., Delbrouk J.M., Serum trace elements during chemotherapy for acute myelogenous leukemia. Acta Pharmacol Toxicol 1985; 59: 270-3.
71. Hrgovic M., Tessmer C.F., Minckler T.M., Serum copper concentrations in lymphoma and leukemia. Cancer 1986; 21: 743-55.
72. Antila H.M., Salo M.S., Kirvela O., Serum trace element concentrations and iron metabolism in allogeneic marrow transplant recipients. Ann Med 1992;24: 55-59.
73. Puri P., Kenny D., Guiney E.J. The need to consider changes in plasma proteins in interpreting postoperative plasma zinc changes. Clin Chim Acta 1981; 110: 341-4.
74. Cunningham B.A., Lenssen P., Aker S.N., Nutritional considerations during marrow transplantation. Nurs Clin North Am 1983; 18: 585-96.
75. Aker S.N., Lenssen P., Darbinian J., Nutritional assessment in the marrow transplant patient. Nutr Support Serv 1983; 3(10):22-37.
76. Cohn S.H., Ellis K.J., Vorsky D., Comparison of methods of estimating body fat in normal subjects and cancer patients. Am J Clin Nutr 1981; 34: 2839-47.
77. Reed M.D., Lazarus H.M., Herzig R.H., Cyclic parenteral nutrition during bone marrow transplantation in children. Cancer 1983; 51: 1563-70.
78. Uderzo C., Rovelli A., Bonomi M., Total parenteral nutrition and nutritional assessment in leukaemic children undergoing bone marrow transplantation. Eur J Cancer 1991; 27: 758-62.
79. Szeluga D.J., Stuart R.K., Brookmeyer R., Energy requirements of parenterally fed bone marrow transplant recipients. JPEN 1985; 9: 139-43.
80. Kaproth P.L., Barber J.R., Moore R., Parenteral nutrition in a bone marrow transplant patient with hepatic complications. NCP 1990; 5: 18-22.
81. Driedeger L., Burstall C.D. Bone marrow transplantation: dietician's experience and perspective. J Am Diet Assoc 1987; 87: 1387-8.
82. American College of Physicians. Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med 1989; 110: 734-6.
83. Michallet M., Hollard D., Guignier A.M., Parenteral nutrition in patients with leukemia and non-Hodgkin malignant lymphoma under chemotherapy. JPEN 1979; 3: 247-54.
84. Issell B.F., Valdiwieso M., Zaren H.A., Protection against chemotherapy toxicity by IV hyperalimentation. Cancer Treat Rep 1978; 62: 1139-43.
85. Shamberger R.C., Pizzo P.A., Goodgame J.T., The effect of total parenteral nutrition or chemotherapy induced myelosuppression. Am J Med 1983; 74: 40-48.
86. Hays D.M., Merritt L.J., White L., Effect of total parenteral nutrition on marrow recovery during induction therapy for acute non-lymphocytic leukemia in childhood. Med Pediatr Oncol 1983; 11: 134-40.
87. Weisdorf S.A., Lysne J., Wind D., Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987; 43: 833-8.
88. Yokoyama S., Fiyimoto T., Mitomi T. Use of total parenteral nutrition in pediatric bone marrow transplantation. Nutrition 1989;5: 27-30.
89. Szeluga P.J., Stuart R.K., Brookmeyer R., Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987; 47: 3309-16.
90. Mulder P.O.M., Bouman J.G., Gietema J.A., Hyperalimentation in autologous bone marrow transplantation for solid tumors. Cancer 1989; 64: 2045-52.
91. Deitch E.A., Winterton J., Li M., The gut as a portal of entry for bacteremia. Ann Surg 1987; 205: 681-92.
92. Brodey G.P. Antibiotic prophylaxis in cancer patients. Regimens of oral, nonabsorbable antibiotics for the prevention of infection during induction of remission. Rev Infect Dis 1981; 3(suppl):S259-S268.
93. Wilmore D.W., Smith R.J., O'Dwyer S.T., The gut: a central organ after surgical stress. Surgery 1988; 104: 917-923.
94. Katz D.P., Kwetan V., Askanazi J. Enteral nutrition: potential role in regulating immune function. Curr Opin Gastroenterol 1990; 6: 199-203.
95. Alverdy J.C., Aoys E., Moss G.S. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 1988; 104: 185-90.
96. Furst P., Albers S., Stehle P. Glutamine-containing dipeptides in parenteral nutrition. JPEN 1990; 14(suppl):118S-124S
97. Locks H., Hubl W. Metabolic basis for selecting glutamine containing substrates for parenteral nutrition. JPEN 1990; 14(suppl):114S-117S.
98. Alverdy J.C. Effects of glutamine supplemented diets on immunology of the gut. JPEN 1990; 14(suppl):109S-113S.
99. Ziegler T.R., Young L.S., Benfell K., Clinical and metabolic effects of glutamine supplemented parenteral nutrition after bone marrow transplantation. Ann Int Med 1992; 116: 821-8.
100. Daly J.M., Reynolds J., Thom A., Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208: 512-22.
101. Barbul A. Arginine and immune functions. Nutrition 1990; 6(Suppl):S53-S58.
102. Reynolds J.V., Daly J.M., Shou J., Immunologic effects of arginine supplementation in tumor-bearing and nontumorbearing hosts. Ann Surg 1990; 211: 202-10.
103. Lieberman M.D., Shou J., Torres A., Effects of nutrient substrates on immune function. Nutrition 1990;6: 88-91.
104. Alexander J.W., Saito H., Ogle C., The importance of lipid type in the diet after burn injury. Ann Surg 1986; 204: 1.
105. Endres S., Ghorbani R., Kelley V.E., The effect of dietary supplementation with N-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cell. N Engl J Med 1989; 320: 265.